FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

773956002: Lanadelumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3727208013 Lanadelumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3727209017 Lanadelumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanadelumab Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Lanadelumab Is a Substance with kallikrein inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Lanadelumab Has disposition Kallikrein inhibitor true Inferred relationship Existential restriction modifier
Lanadelumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Lanadelumab Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing lanadelumab (medicinal product) Has active ingredient True Lanadelumab Inferred relationship Existential restriction modifier 1
Product containing lanadelumab in parenteral dose form (medicinal product form) Has active ingredient True Lanadelumab Inferred relationship Existential restriction modifier 1
Lanadelumab Has active ingredient True Lanadelumab Inferred relationship Existential restriction modifier 1
Product containing only lanadelumab in parenteral dose form (medicinal product form) Has active ingredient True Lanadelumab Inferred relationship Existential restriction modifier 1
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Lanadelumab Inferred relationship Existential restriction modifier 1
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Lanadelumab Inferred relationship Existential restriction modifier 1
Lanadelumab 300mg/2ml solution for injection pre-filled syringes Has specific active ingredient True Lanadelumab Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection pre-filled syringes (Takeda UK Ltd) 1 pre-filled disposable injection Has specific active ingredient True Lanadelumab Inferred relationship Existential restriction modifier
Lanadelumab 300mg/2ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Lanadelumab Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection pre-filled syringes (Takeda UK Ltd) Has specific active ingredient True Lanadelumab Inferred relationship Existential restriction modifier
Lanadelumab 300mg/2ml solution for injection vials 1 vial Has specific active ingredient True Lanadelumab Inferred relationship Existential restriction modifier
Lanadelumab 300mg/2ml solution for injection vials Has specific active ingredient True Lanadelumab Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial Has specific active ingredient True Lanadelumab Inferred relationship Existential restriction modifier
Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) Has specific active ingredient True Lanadelumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start